Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Iot save search
Tempest to Participate in William Blair 2021 Biotech Focus Conference
Published: 2021-07-09 (Crawled : 12:00) - globenewswire.com
TPST | $3.18 -2.75% -2.83% 320K
|
Manufacturing
|
| O: 0.38%
H: 137.61%
C: 48.81%
pest biotech iot conference
Sensei Biotherapeutics Announces New Clinical Data from the Ongoing Phase 1/2 Combination Trial of SNS-301 in Patients with Squamous Cell Carcinoma of the Head and Neck
Published: 2021-05-19 (Crawled : 22:00) - globenewswire.com
SNSE | $0.98 -2.0% -2.04% 32K
|
|
| O: 0.82%
H: 35.47%
C: 29.05%
ongoing phase 1 iot trial phase 3 phase 2 cell carcinoma
Edesa Biotech Announces Positive Phase 2 Data of Its Monoclonal Antibody in Hospitalized COVID-19 Patients
Published: 2021-09-20 (Crawled : 12:15) - biospace.com/
EDSA | $4.4 -2.3% 1.4K
|
Health Technology
|
| O: 68.6%
H: 26.98%
C: 26.14%
covid phase 2 positive antibody biotech iot covid-19
9 Meters Biopharma, Inc. To Present at the William Blair Biotech Focus Conference
Published: 2021-07-08 (Crawled : 12:00) - biospace.com/
NMTR | $0.0722 -42.97% -67.9% 10M
|
Health Technology
|
| O: 1.75%
H: 35.5%
C: 18.32%
biopharma biotech iot conference
Protalix BioTherapeutics and Chiesi Global Rare Diseases Receive Complete Response Letter for Pegunigalsidase Alfa from FDA
Published: 2021-04-28 (Crawled : 07:00) - biospace.com/
PLX | $1.13 -1.74% 0.0% 420K
|
Health Services
|
| O: -42.54%
H: 31.34%
C: 17.31%
disease fda iot response rare
Protalix BioTherapeutics Provides Update on Complete Response Letter for Pegunigalsidase Alfa from the FDA
Published: 2021-04-28 (Crawled : 18:00) - biospace.com/
PLX | $1.13 -1.74% 0.0% 420K
|
Health Services
|
| O: -42.54%
H: 31.34%
C: 17.31%
fda iot response
PDS Biotech Announces Release of Abstract for PDS0101 in NCI-Led Phase 2 Clinical Study for Oral Presentation at 2021 ASCO Meeting
Published: 2021-05-20 (Crawled : 12:15) - globenewswire.com
PDSB | $2.89 6.25% 5.88% 1.1M
|
Health Technology
|
| O: 8.01%
H: 25.81%
C: 17.26%
presentation phase 2 biotech iot
UNITY Biotechnology, Inc. Reports Third Quarter 2021 Financial Results and Business Updates
Published: 2021-11-10 (Crawled : 17:00) - globenewswire.com
UBX | $1.5 -0.33% -0.33% 28K
|
Health Technology
|
| O: 16.74%
H: 33.82%
C: 16.54%
financial results results biotech technology iot
Ocugen Partner, Bharat Biotech, Announces Positive Immunogenicity and Safety Data From COVAXIN™ (BBV152), COVID-19 Candidate Vaccine, in Children 2 – 18 YEARS
Published: 2021-12-30 (Crawled : 15:30) - globenewswire.com
OCGN | News A | $1.315 -8.68% -9.51% 8M
|
Health Technology
|
| O: -4.79%
H: 21.34%
C: 15.83%
bbv152 covid-19 xin covid positive children biotech vaccine iot
Actelis Selected and Receives First Order to Provide IoT Networking To European Natural Gas System Operator
Published: 2023-10-17 (Crawled : 12:30) - globenewswire.com
ASNS | $0.6712 -4.76% 3.6K
|
|
| O: 8.47%
H: 32.03%
C: 15.63%
natural gas iot system order
Riot Blockchain Announces Financial Results and Operating Highlights for the Year Ended December 31, 2021
Published: 2022-03-16 (Crawled : 22:00) - globenewswire.com
RIOT | $8.3 4.14% 3.98% 17M
|
Finance
|
| O: -1.65%
H: 14.7%
C: 14.33%
financial results blockchain results iot
Sequans Integrates MicroEJ Edge Container on its Monarch 2 LTE-M/NB-IoT Platform
Published: 2022-02-24 (Crawled : 13:30) - prnewswire.com
SQNS | $0.5769 9.47% -0.59% 220K
|
Electronic Technology
|
| O: -5.36%
H: 15.01%
C: 13.6%
iot platform
PDS Biotech Announces Preliminary Safety Data on PDS0101 in Combination With KEYTRUDA® (pembrolizumab) at the 2022 Multidisciplinary Head and Neck Cancers Symposium
Published: 2022-02-24 (Crawled : 15:30) - globenewswire.com
PDSB | $2.89 6.25% 5.88% 1.1M
|
Health Technology
|
| O: -7.03%
H: 14.74%
C: 13.42%
pds0101 keytruda symposium cancer head and neck biotech iot
PDS Biotechnology Appoints Immuno-Oncology Experts Dr. Olivera Finn and Dr. Mark Frohlich to Scientific Advisory Board
Published: 2021-05-18 (Crawled : 13:15) - biospace.com/
PDSB | $2.89 6.25% 5.88% 1.1M
|
Health Technology
|
| O: 0.41%
H: 14.6%
C: 13.39%
biotech technology iot liver
Legend Biotech Reports First Quarter 2021 Financial Results and Recent Highlights
Published: 2021-05-18 (Crawled : 13:00) - biospace.com/
LEGN | $47.16 -3.42% -3.54% 820K
|
Health Technology
|
| O: 0.81%
H: 14.65%
C: 13.32%
financial results results biotech iot
Portage Biotech Highlights First Patient Dosed in IMP-MEL Study of PORT-2 for the Treatment of Melanoma and Non-Small Cell Lung Cancer (NSCLC)
Published: 2021-08-05 (Crawled : 12:00) - globenewswire.com
PRTG | $0.299 35.17% 26.02% 140K
|
Mining, Quarrying, and Oil and ...
|
| O: 1.25%
H: 13.6%
C: 12.88%
treatment lung cancer cancer biotech iot
SEALSQ To Launch SEALCOIN, a digital token and advanced cryptocurrency protocol, at the Davos Space IoT and Cybersecurity Event on January 17, 2024
Published: 2024-01-03 (Crawled : 12:00) - globenewswire.com
LAES | $1.08 1.89% 1.85% 220K
|
n/a
|
| O: 7.69%
H: 23.02%
C: 12.7%
WKEY | $2.14 2.68% 11K
|
Technology Services
|
| O: 1.35%
H: 7.44%
C: 2.66%
iot space cybersecurity advanced
BlueIOT to Deploy Advanced Real-Time Locating System in Indonesian Hospital this Spring
Published: 2022-03-18 (Crawled : 14:30) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -1.19%
H: 12.69%
C: 12.69%
system blue one iot
SAB Biotherapeutics Reports Positive Phase 2 Virology Data Demonstrating SAB-185 Met Criteria for Advancement to Phase 3 in NIH ACTIV-2 Trial for Treatment of COVID-19
Published: 2022-01-24 (Crawled : 12:00) - biospace.com/
SABS | $4.61 0.22% 0.22% 2.9K
|
|
| O: -3.74%
H: 14.05%
C: 12.57%
sab-185 covid-19 treatment phase 2 trial therapeutics covid report positive phase 3 iot
Actelis Announces Order Received and Launch of New Last Mile Hybrid-Fiber Multi-Gigabit Broadband Solution For Buildings and IoT Applications
Published: 2023-12-14 (Crawled : 13:30) - globenewswire.com
ASNS | $0.6712 -4.76% 3.6K
|
|
| O: 1.79%
H: 16.67%
C: 12.28%
solution iot order
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.